(Q36225073)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16093408%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

New therapeutic approaches to Parkinson's disease including neural transplants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16093408%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16093408%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Roger A. Barker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16093408%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Kuan WL

series ordinal

1

1 reference

12 August 2017

Barker RA

series ordinal

2

1 reference

12 August 2017

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16093408%20AND%20SRC:MED&resulttype=core&format=json

Neurorehabilitation and Neural Repair

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16093408%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16093408%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16093408%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

155-181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16093408%20AND%20SRC:MED&resulttype=core&format=json

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Effects of reversible blockade of basal ganglia on a voluntary arm movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Apomorphine induces changes in GPi spontaneous outflow in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Effects of apomorphine on globus pallidus neurons in parkinsonian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Surgical treatment for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Mechanisms of deep brain stimulation: excitation or inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Effect of an Opiate Antagonist on Movement Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioural observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Buspirone in the treatment of levodopa induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The effect of deprenyl and levodopa on the progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Ropinirole for the treatment of tremor in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Effect of riluzole on dyskinesia and duration of the on state in Parkinson disease patients: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Prospects for the treatment of Parkinson's disease using neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The potential of GDNF as a treatment for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neural transplantation for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Lazaroids improve the survival of grafted rat embryonic dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Functional and anatomical reconstruction of the 6-hydroxydopamine lesioned nigrostriatal system of the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neurobiology. Better cells for brain repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Caspase inhibition reduces apoptosis and increases survival of nigral transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Addition of allogeneic spleen cells causes rejection of intrastriatal embryonic mesencephalic allografts in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Analysis of neural stem cells by flow cytometry: cellular differentiation modifies patterns of MHC expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

21 January 2018

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neuroprotection of grafted neurons with a GDNF/caspase inhibitor cocktail

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

In vitro evaluation of the antioxidant activity and biomembrane interaction of the lazaroid U-74389G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Combined inhibition of apoptosis and complement improves neural graft survival of embryonic rat and porcine mesencephalon in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Intrastriatal transplantation of Sertoli cells may improve amphetamine-induced rotation and tyrosine hydroxylase immunoreactivity of the striatum in hemiparkinsonian rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Sertoli cells enhance the survival of co-transplanted dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neurobehavioral assessment of transplanted porcine Sertoli cells into the intact rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Enhanced survival of cultured dopamine neurons by treatment with soluble extracts from chemically deafferentiated striatum of adult rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Striatal extracts promote the survival and phenotypic expression of rat fetal dopaminergic neurons in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons--I. Effects in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The high molecular weight fibroblast growth factor-2 isoforms (21,000 mol. wt and 23,000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

High molecular weight basic fibroblast growth factor-like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Brain-derived neurotrophic factor-transduced fibroblasts: production of BDNF and effects of grafting to the adult rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle trans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical con

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neuroche

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Lipid-mediated glial cell line-derived neurotrophic factor gene transfer to cultured porcine ventral mesencephalic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Delayed implantation of nigral grafts improves survival of dopamine neurones and rate of functional recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The release of excitatory amino acids, dopamine, and potassium following transplantation of embryonic mesencephalic dopaminergic grafts to the rat striatum, and their effects on dopaminergic neuronal survival in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Excitotoxicity plays a role in the death of tyrosine hydroxylase- immunopositive nigral neurons cultured in serum-free medium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Elevated potassium enhances glutamate vulnerability of dopaminergic neurons developing in mesencephalic cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

MK-801 does not enhance dopaminergic cell survival in embryonic nigral grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Different mechanisms mediate the rejection of porcine neurons and endothelial cells transplanted into the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Time-dependent expression of donor- and host-specific major histocompatibility complex class I and II antigens in allogeneic dopamine-rich macro- and micrografts: comparison of two different grafting protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Enhanced survival of porcine neural xenografts in mice lacking CD1d1, but no effect of NK1.1 depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from MHC-deficient mice to adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Simultaneous inhibition of B7 and LFA-1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Induction of operational tolerance to discordant dopaminergic porcine xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Human natural antibodies cytotoxic to pig embryonic brain cells recognize novel non-Galalpha1,3Gal-based xenoantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Alpha Gal is widely expressed in embryonic porcine stem cells and neural tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Immune parameters relevant to neural xenograft survival in the primate brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Xenotransplantation for brain repair: reduction of porcine donor tissue immunogenicity by treatment with anti-Gal antibodies and complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Discordant neural tissue xenografts survive longer in immunoglobulin deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Poly(vinyl alcohol) synthetic polymer foams as scaffolds for cell encapsulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Repulsive and inhibitory signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Robust regeneration of CNS axons through a track depleted of CNS glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The immunosuppressant drug FK506 is a potent trophic agent for human fetal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Chondroitin sulphate proteoglycans: inhibitory components of the glial scar

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFbeta1 and beta2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Chondroitin and keratan sulfates have opposing effects on attachment and outgrowth of ventral mesencephalic explants in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neuritogenic and survival-promoting effects of the P2 peptide derived from a homophilic binding site in the neural cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Coordinate expression of L1 and 6B4 proteoglycan/phosphacan is correlated with the migration of mesencephalic dopaminergic neurons in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

L1 substrate enhances outgrowth of tyrosine hydroxylase-immunoreactive neurites in mesencephalic cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Bcl-2 promotes regeneration of severed axons in mammalian CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Overexpression of Bcl-2 in a murine dopaminergic neuronal cell line leads to neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Bruton's tyrosine kinase phosphorylates cAMP-responsive element-binding protein at serine 133 during neuronal differentiation in immortalized hippocampal progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Bridge grafts of fibroblast growth factor-4-secreting schwannoma cells promote functional axonal regeneration in the nigrostriatal pathway of the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Grafted swine neuroepithelial stem cells can form myelinated axons and both efferent and afferent synapses with xenogeneic rat neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Differential neurite growth on astrocyte substrates: interspecies facilitation in green fluorescent protein-transfected rat and human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

A morphometric study of the carotid body in chronically hypoxic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Autotransplantation of superior cervical ganglion to the caudate nucleus in three patients with Parkinson's disease (preliminary report).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Autologous transplantation of the cervical sympathetic ganglion into the parkinsonian brain: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The trophic cocktail made by adrenal chromaffin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Clinical experience with cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Clinical outcome of cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease. Clínica Puerta de Hierro Neural Transplantation Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Production of dopaminergic neurons for cell therapy in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

In vitro generation and transplantation of precursor-derived human dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

The controlled conversion of human neural progenitor cells derived from foetal ventral mesencephalon into dopaminergic neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Characterization of the expression of MHC proteins in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Deep brain stimulation for Parkinson’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Additive Effects of Caspase Inhibitor and Lazaroid on the Survival of Transplanted Rat and Human Embryonic Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Flunarizine improves the survival of grafted dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Tau EGFP embryonic stem cells: An efficient tool for neuronal lineage selection and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

Neuronal cell–cell adhesion depends on interactions of N-CAM with heparin-like molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968305277219

21 January 2018

Identifiers

DOI

10.1177/1545968305277219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16093408%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference